15/10/2026
For some children with cancer, a clinical trial may be their best, or only, treatment option. Yet too often, the right trial isn't available in Australia.
We're proud to share the release of Building a Future of Life-Saving Clinical Trials for Children with Cancer, a new white paper that sets out a roadmap to attract more industry-sponsored paediatric oncology clinical trials to Australia and improve access to innovative treatments for children and young people facing cancer. Children’s Cancer Institute participated in the roundtable that informed the white paper.
Australia has built one of the world's most advanced paediatric oncology ecosystems, supported by initiatives including the Zero Childhood Cancer Program (ZERO), which has already analysed cancers from close to 4,000 children and young people. Yet only seven industry-sponsored paediatric oncology trials were active in Australia in the 12 months to June 2026.
The white paper identifies four practical reforms to help Australia become a global destination for children's cancer trials, ensuring more children can access potentially life-saving therapies closer to home. These include better coordination across the sector, stronger data integration, expanded access through teletrials and shared-care models, and regulatory and reimbursement reforms that better support paediatric medicine development.
Meaningful change will require industry, clinicians, researchers and governments working together. Because where a child lives should never determine whether they can access the most promising treatments available.
Find our more or read the white paper at https://ow.ly/wV8Y50ZXSkb